Literature DB >> 2256752

Correlation of iron exchange between the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one(L1) and transferrin and possible antianaemic effects of L1 in rheumatoid arthritis.

G Vreugdenhil, A J Swaak, C de Jeu-Jaspers, H G van Eijk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2256752      PMCID： PMC1004279          DOI： 10.1136/ard.49.11.956-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

1.  Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness.

Authors:  G Vreugdenhil; A W Wognum; H G van Eijk; A J Swaak
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  The anaemia of chronic disorders.

Authors:  G E Cartwright; G R Lee
Journal:  Br J Haematol       Date:  1971-08       Impact factor: 6.998

3.  The measurement of reticuloendothelial iron release using iron-dextran.

Authors:  M R Beamish; A G Davies; J D Eakins; A Jacobs; D Trevett
Journal:  Br J Haematol       Date:  1971-12       Impact factor: 6.998

4.  Investigation of the anti-inflammatory properties of hydroxypyridinones.

Authors:  S D Hewitt; R C Hider; P Sarpong; C J Morris; D R Blake
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

5.  Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases.

Authors:  P Biemond; H G van Eijk; A J Swaak; J F Koster
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Treatment of rheumatoid arthritis with desferrioxamine.

Authors:  R J Polson; A S Jawad; A Bomford; H Berry; R Williams
Journal:  Q J Med       Date:  1986-12

7.  Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis.

Authors:  N Giordano; S Sancasciani; C Borghi; A Fioravanti; R Marcolongo
Journal:  Clin Exp Rheumatol       Date:  1986 Jan-Mar       Impact factor: 4.473

8.  Effect of a specific iron chelating agent on animal models of inflammation.

Authors:  D R Blake; N D Hall; P A Bacon; P A Dieppe; B Halliwell; J M Gutteridge
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

9.  Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism?

Authors:  M O'Connell; B Halliwell; C P Moorhouse; O I Aruoma; H Baum; T J Peters
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

10.  Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors:  G J Kontoghiorghes; M A Aldouri; A V Hoffbrand; J Barr; B Wonke; T Kourouclaris; L Sheppard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12
View more
  3 in total

1.  Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.

Authors:  Yang-Sung Sohn; Anna-Maria Mitterstiller; William Breuer; Guenter Weiss; Z Ioav Cabantchik
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

Review 3.  Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  Drug Des Devel Ther       Date:  2016-01-29       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.